Variant report
Variant | esv3330349 |
---|---|
Chromosome Location | chr7:124249050-124277678 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs529707436 | chr7:124258606-124258607 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs376998672 | chr7:124258621-124258622 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs146194103 | chr7:124258628-124258629 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs565897362 | chr7:124258641-124258642 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs535016117 | chr7:124258667-124258668 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs4295588 | chr7:124258675-124258676 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
7 | rs571597828 | chr7:124258711-124258712 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs537443129 | chr7:124258712-124258713 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs546511998 | chr7:124258743-124258744 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs574103139 | chr7:124258758-124258759 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs543109394 | chr7:124258789-124258790 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs553238784 | chr7:124258792-124258793 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs573055733 | chr7:124258833-124258834 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs138797381 | chr7:124258835-124258836 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs61617280 | chr7:124258837-124258838 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
16 | rs530678874 | chr7:124258859-124258860 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs185723258 | chr7:124258995-124258996 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs377166665 | chr7:124259037-124259038 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs529751866 | chr7:124259044-124259045 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs576237791 | chr7:124259083-124259084 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs546271658 | chr7:124259119-124259120 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs543560902 | chr7:124259149-124259150 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs565961000 | chr7:124259150-124259151 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs548653089 | chr7:124259196-124259197 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs528659099 | chr7:124259230-124259231 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs76337169 | chr7:124259236-124259237 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs368967711 | chr7:124259248-124259249 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs114610330 | chr7:124259264-124259265 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs565352093 | chr7:124259327-124259328 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs71520305 | chr7:124267810-124267811 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs398048073 | chr7:124267821-124267822 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs148563923 | chr7:124267841-124267842 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs1404412 | chr7:124267864-124267865 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
34 | rs538462408 | chr7:124267885-124267886 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs193178881 | chr7:124267892-124267893 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs185292558 | chr7:124267895-124267896 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs537711816 | chr7:124267930-124267931 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs189791441 | chr7:124267943-124267944 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs77315753 | chr7:124267956-124267957 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs539984594 | chr7:124267958-124267959 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs35936075 | chr7:124268026-124268027 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
42 | rs576825904 | chr7:124268040-124268041 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs566678134 | chr7:124268043-124268044 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs78093751 | chr7:124268047-124268048 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs569709699 | chr7:124268050-124268051 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs1917357 | chr7:124268066-124268067 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
47 | rs558627219 | chr7:124268086-124268087 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs544900765 | chr7:124268151-124268152 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs142547798 | chr7:124268160-124268161 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs147167020 | chr7:124268170-124268171 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular cancer | 18059402 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Autism | 19415332 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Malaria | 21533027 | CNVD |
Melanoma | 18172304 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
head and neck squamous cell carcinoma | 19289630 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 22495311 | CNVD |
Wilms tumour | 21544195 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Low-grade fibromyxoid sarcoma | 0 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Breast cancer | 21264507 | CNVD |
Shwachman-Diamond syndrome | 22934832 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Cutaneous malignant melanoma | 17690212 | CNVD |
Leukemia | 17361228 | CNVD |
Breast cancer | 16461572 | CNVD |
Peripheral t-cell lymphoma | 19118030 | CNVD |
Malignant melanoma | 17690212 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
abortions and stillbirths | 19751515 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Lung cancer | 18438408 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Prostate cancer | 16573809 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Biliary cancer | 19435499 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Prostate cancer | 23792589 | CNVD |
Adenocarcinoma | 21044232 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Non-small cell lung cancer | 19889201 | CNVD |
Acute myeloid leukemia | 18000384 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
Metastatic melanoma | 18483359 | CNVD |
Autism | 18414403 | CNVD |
Autism | 19401682 | CNVD |
Autism | 19546859 | CNVD |
Schizophrenia | 19546859 | CNVD |
Tourette syndrome | 19546859 | CNVD |
Melanoma | 19188590 | CNVD |
Hepatocellular carcinoma | 16785998 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Breast cancer | 21509527 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Epilepsy | 21635232 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
abnormal development | 18461090 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Melanoma | 20877625 | CNVD |
Breast cancer | 22522925 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr7:124258600-124259400 | Enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |
2 | chr7:124267800-124268600 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
3 | chr7:124268600-124270000 | Weak transcription | Foreskin Melanocyte Primary Cells skin03 | Skin |
4 | chr7:124270000-124271400 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
5 | chr7:124270600-124271600 | Enhancers | Fetal Brain Female | brain |
6 | chr7:124271400-124287600 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
7 | chr7:124274200-124274400 | ZNF genes & repeats | iPS DF 19.11 Cell Line | embryonic stem cell |
8 | chr7:124274400-124285800 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
9 | chr7:124275200-124275600 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
10 | chr7:124275200-124277000 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
11 | chr7:124275400-124275800 | Enhancers | ES-WA7 Cell Line | embryonic stem cell |
12 | chr7:124275400-124275800 | Enhancers | HUES48 Cell Line | embryonic stem cell |
13 | chr7:124275400-124276400 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
14 | chr7:124275600-124276000 | Flanking Active TSS | iPS-20b Cell Line | embryonic stem cell |
15 | chr7:124275800-124276200 | Flanking Active TSS | HUES48 Cell Line | embryonic stem cell |
16 | chr7:124275800-124276400 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
17 | chr7:124275800-124276800 | Enhancers | HUES6 Cell Line | embryonic stem cell |
18 | chr7:124275800-124276800 | Enhancers | HUES64 Cell Line | embryonic stem cell |
19 | chr7:124276000-124276800 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
20 | chr7:124276000-124277200 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
21 | chr7:124276200-124277200 | Enhancers | HUES48 Cell Line | embryonic stem cell |
22 | chr7:124276800-124280400 | Weak transcription | HUES64 Cell Line | embryonic stem cell |
23 | chr7:124277000-124280400 | Weak transcription | iPS-18 Cell Line | embryonic stem cell |